News search

E.g., 24/07/2026
E.g., 24/07/2026
eLife
About the CNIC
21 Jul 2026

The study reveals that the early heart is shaped by distinct but closely coordinated patterns of tissue deformation 

Diana Velázquez, Natalia Vicente, Jon Sicilia, María Rosaria Pricolo, Laura Sen, Jorge Alegre y Agata Bak.
Research
7 Jul 2026

Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes

Rocío Sierra, Miguel Torres, Cristina Villa del Campo, Enrique Calvo, Jesús Vázquez y Consuelo Marín-Vicente.
Research
24 Jun 2026

Two CNIC teams have developed a pioneering technique to analyze proteins in individual cardiomyocytes and uncover new clues about cardiac regeneration

Florian Weinberg
About the CNIC
23 Jun 2026

CARDIOSWITCH aims to uncover how the mechanical activity of heart muscle cells shapes cardiac biology and to develop new regenerative strategies for congenital heart disease

About the CNIC
11 Jun 2026

The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease

Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
Research
21 Apr 2026

The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.

From left to right, Borja Ibáñez, Laura Cádiz, Agustín Clemente Moragón, Ángela Pollán, Lucía López Palomar, and Anabel Díaz Guerra.
Research
26 Feb 2026

The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines

Ana Simón Chica y David Filgueiras Rama
Research
10 Feb 2026

The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia

Foto
Research
5 Feb 2026

prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction.